GASTROESOPHAGEAL JUNCTION
Clinical trials for GASTROESOPHAGEAL JUNCTION explained in plain language.
Never miss a new study
Get alerted when new GASTROESOPHAGEAL JUNCTION trials appear
Sign up with your email to follow new studies for GASTROESOPHAGEAL JUNCTION, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New hope for stomach cancer: experimental drug cocktails enter human trials
Disease control Recruiting nowThis study tests two new drug combinations for people with advanced stomach, gastroesophageal junction, or esophageal cancer that has gotten worse after one prior treatment. About 210 participants will receive either an experimental antibody-drug combo plus standard chemo, or sta…
Matched conditions: GASTROESOPHAGEAL JUNCTION
Phase: PHASE1, PHASE2 • Sponsor: Merck Sharp & Dohme LLC • Aim: Disease control
Last updated May 14, 2026 12:05 UTC
-
New hope for stomach cancer: experimental drug combo trial opens
Disease control Recruiting nowThis study tests whether adding new investigational drugs to standard chemotherapy and immunotherapy (pembrolizumab) can safely treat advanced stomach, gastroesophageal junction, or esophageal cancer that has not spread to other organs. About 160 adults whose cancer is HER2-negat…
Matched conditions: GASTROESOPHAGEAL JUNCTION
Phase: PHASE1, PHASE2 • Sponsor: Merck Sharp & Dohme LLC • Aim: Disease control
Last updated May 11, 2026 20:54 UTC
-
New PET scan could spot hidden cancer spread in stomach and esophageal cancers
Diagnosis Recruiting nowThis study tests a new type of PET scan called [18F]FAPI-74 to see if it can better find cancer that has spread in adults with stomach or esophageal cancer. About 200 participants will get one dose of the scan tracer and be followed for up to 3 months. The goal is to see if this …
Matched conditions: GASTROESOPHAGEAL JUNCTION
Phase: PHASE3 • Sponsor: SOFIE • Aim: Diagnosis
Last updated May 13, 2026 16:02 UTC